Send to

Choose Destination
Oncotarget. 2018 Aug 17;9(64):32276-32277. doi: 10.18632/oncotarget.25971. eCollection 2018 Aug 17.

Disabling an oncogenic transcription factor by targeting of control kinases.

Author information

Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY, USA; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.


kinase; leukemia; therapy; transcription factor

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center